The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...
Annual Recurring Revenue was $603.1M, up 17.7% year-over-year. “Vertex’s (VERX) 2024 financial results demonstrated the power of our business and financial model, which is built to deliver ...